Fusion Pharmaceuticals (FUSN) Institutional Ownership → Breaking - The US Gov. Seized CITGO (From Augury Research) (Ad) Free FUSN Stock Alerts $21.55 0.00 (0.00%) (As of 06/4/2024) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Fusion Pharmaceuticals (NASDAQ:FUSN)CurrentInstitutional OwnershipPercentage72.85%Number ofInstitutional Buyers(last 12 months)33TotalInstitutional Inflows(last 12 months)$63.19MNumber ofInstitutional Sellers(last 12 months)6TotalInstitutional Outflows(last 12 months)$7.52M Get FUSN Insider Trade Alerts Want to know when executives and insiders are buying or selling Fusion Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data FUSN Institutional Buying and Selling by Quarter Ad HedgeyeNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analysis meets hedge fund-level market foresight!TRY "INVESTING IDEAS" TODAY Fusion Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/20/2024 Virtu Financial LLC28,917$616K0.0%N/A0.034% 5/20/2024 Bluefin Capital Management LLC10,000$213K0.0%N/A0.012% 5/16/2024 Jane Street Group LLC633,932$13.52M0.0%+2,153.4%0.745% 5/16/2024 California State Teachers Retirement System39,041$832K0.0%N/A0.046% 5/16/2024 KRYGER CAPITAL Ltd100,284$2.14M0.4%N/A0.118% 5/16/2024 Beryl Capital Management LLC16,191$345K0.4%N/A0.019% Get the Latest News and Ratings for FUSN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Fusion Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 5/15/2024 GABELLI & Co INVESTMENT ADVISERS INC.115,750$2.47M0.4%N/A0.136% 5/15/2024 Gabelli Funds LLC146,150$3.12M0.0%N/A0.172% 5/15/2024 Gamco Investors INC. ET AL11,450$244K0.0%N/A0.013% 5/14/2024 Natixis99,000$2.11M0.0%N/A0.116% 5/10/2024 Maso Capital Partners Ltd150,000$3.20M2.4%N/A0.177% 5/9/2024 Chicago Capital Management LLC170,200$3.63M3.8%N/A0.201% 5/9/2024 Blair William & Co. IL779,202$16.61M0.1%-21.6%0.918% 5/8/2024 ProShare Advisors LLC17,623$376K0.0%N/A0.021% 5/7/2024 Swiss National Bank85,700$1.83M0.0%N/A0.101% 4/30/2024 Privium Fund Management B.V.251,158$5.36M1.5%+77.2%0.296% 4/29/2024 China Universal Asset Management Co. Ltd.13,920$297K0.0%+66.2%0.016% 3/5/2024 Wellington Management Group LLP744,474$7.15M0.0%N/A1.028% 2/15/2024 Forefront Analytics LLC16,715$161K0.1%-50.4%0.023% 2/14/2024 Avidity Partners Management LP6,500,328$62.47M2.3%+12.4%8.978% 2/14/2024 Superstring Capital Management LP45,801$440K0.3%N/A0.063% 2/13/2024 Tower Research Capital LLC TRC3,008$29K0.0%+2,064.0%0.004% 2/13/2024 NEOS Investment Management LLC30,939$297K0.0%+76.9%0.043% 2/7/2024 Jump Financial LLC86,199$828K0.0%N/A0.119% 2/1/2024 New York State Common Retirement Fund6,630$64K0.0%N/A0.009% 2/1/2024 Jennison Associates LLC301,020$2.89M0.0%N/A0.416% 2/1/2024 Signaturefd LLC2,949$28K0.0%+883.0%0.004% 1/31/2024 abrdn plc21,697$209K0.0%N/A0.030% 1/31/2024 Federated Hermes Inc.10,886,153$104.62M0.3%+1.9%15.034% 1/30/2024 HealthInvest Partners AB125,000$1.20M0.9%N/A0.173% 1/24/2024 China Universal Asset Management Co. Ltd.8,376$80K0.0%N/A0.012% 1/16/2024 Raymond James Financial Services Advisors Inc.31,145$299K0.0%N/A0.043% 1/12/2024 Yarbrough Capital LLC76,872$739K0.0%N/A0.106% 11/14/2023 Avidity Partners Management LP5,781,850$15.03M0.6%+1.4%7.985% 11/13/2023 Federated Hermes Inc.10,683,789$27.78M0.1%+0.5%14.755% 11/13/2023 FMR LLC4,177,848$10.86M0.0%-10.8%5.770% 11/8/2023 Forefront Analytics LLC33,685$88K0.0%+67.8%0.049% 10/27/2023 Eagle Health Investments LP579,769$1.51M0.3%-14.8%0.840% 8/24/2023 Perceptive Advisors LLC2,751,395$12.85M0.4%-0.3%3.988% 8/15/2023 Sphera Funds Management LTD.1,329,258$6.21M1.0%+3.6%1.926% No Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for Free (Ad)Optimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analysis meets hedge fund-level market foresight!TRY "INVESTING IDEAS" TODAY8/14/2023 Eagle Health Investments LP680,370$3.18M0.6%N/A0.986% 8/11/2023 Artal Group S.A.1,725,000$8.06M0.2%-12.7%2.500% 5/15/2023 Ghost Tree Capital LLC350,000$1.32M0.4%N/A0.554% 5/15/2023 Sio Capital Management LLC246,036$928K0.5%-5.5%0.389% 5/8/2023 Federated Hermes Inc.5,849,100$22.05M0.1%+81.4%9.253% 5/1/2023 Virtu Financial LLC13,084$49K0.0%N/A0.021% 2/15/2023 Braidwell LP2,000,000$6.30M0.2%N/A4.468% 2/10/2023Tekla Capital Management LLC43,394$137K0.0%-57.4%0.097% 11/15/2022 Federated Hermes Inc.3,174,100$9.56M0.0%+1.6%7.091% 11/14/2022 Point72 Asset Management L.P.310,068$933K0.0%-5.7%0.693% 11/14/2022 RA Capital Management L.P.659,992$1.99M0.0%N/A1.474% 11/14/2022UBS Oconnor LLC17,286$52K0.0%N/A0.039% 11/8/2022 Sofinnova Investments Inc.117,099$352K0.0%+50.0%0.270% 11/4/2022 Prudential Financial Inc.14,600$44K0.0%N/A0.034% 11/2/2022 Victory Capital Management Inc.50,390$152K0.0%-72.2%0.116% 11/1/2022Tekla Capital Management LLC101,931$605K0.0%+134.9%0.235% 9/16/2022 Federated Hermes Inc.3,124,100$7.78M0.0%+2.3%7.200% 8/15/2022 Pivotal bioVenture Partners Investment Advisor LLC1,560,982$3.89M2.0%-2.3%3.597% 5/4/2022 Victory Capital Management Inc.183,690$1.30M0.0%-26.6%0.424% 2/25/2022 AlphaCentric Advisors LLC100,000$417K0.1%N/A0.232% 2/14/2022 Perceptive Advisors LLC1,227,017$5.12M0.1%-2.2%2.849% 2/14/2022 Point72 Asset Management L.P.1,048,956$4.37M0.0%+22.3%2.436% 2/7/2022 Victory Capital Management Inc.250,380$1.04M0.0%-6.5%0.581% 12/3/2021 Perceptive Advisors LLC1,254,607$9.94M0.1%-29.3%2.913% 11/15/2021 Point72 Asset Management L.P.858,012$6.80M0.0%-2.0%1.992% 11/15/2021 Sectoral Asset Management Inc38,198$303K0.0%N/A0.089% 11/12/2021 Johnson & Johnson3,670,516$29.07M2.6%N/A8.523% 11/9/2021 BlackRock Inc.414,256$3.28M0.0%-11.9%0.963% 11/2/2021 Victory Capital Management Inc.267,703$2.12M0.0%-0.7%0.622% 8/17/2021 Woodline Partners LP154,597$1.25M0.0%+24.1%0.364% 8/17/2021 Perceptive Advisors LLC1,775,167$14.34M0.2%-9.0%4.181% 8/16/2021 Point72 Asset Management L.P.875,141$7.07M0.0%+16.7%2.061% 8/16/2021 Perceptive Advisors LLC1,775,167$14.34M0.2%-9.0%4.181% 8/16/2021 Federated Hermes Inc.597,841$4.83M0.0%+5.8%1.408% 8/16/2021 Goldman Sachs Group Inc.18,221$147K0.0%+29.5%0.043% 8/13/2021 Adams Street Partners LLC2,973,744$24.03M5.0%-0.5%7.004% 8/13/2021 FMR LLC3,184,209$25.73M0.0%+1.5%7.500% 8/11/2021 BlackRock Inc.470,303$3.80M0.0%-41.8%1.108% 8/3/2021 Victory Capital Management Inc.269,623$2.18M0.0%-5.6%0.635% 5/18/2021 Millennium Management LLC10,726$115K0.0%-76.9%0.025% 5/18/2021 Point72 Asset Management L.P.750,000$8.04M0.0%+36.4%1.766% 5/18/2021 Morgan Stanley76,171$817K0.0%+90.7%0.179% 5/17/2021 Perceptive Advisors LLC1,950,167$20.91M0.3%-12.8%4.593% 5/17/2021 Woodline Partners LP124,594$1.34M0.0%+135.9%0.293% 5/13/2021 Federated Hermes Inc.565,000$6.06M0.0%+7.6%1.331% 5/10/2021 Adams Street Partners LLC2,989,644$32.05M5.1%-14.4%7.044% 5/7/2021 BlackRock Inc.807,536$8.66M0.0%-2.8%1.903% 5/7/2021 Altfest L J & Co. Inc.10,139$109K0.0%N/A0.024% 5/4/2021 Victory Capital Management Inc.285,678$3.06M0.0%+59.1%0.673% 3/12/2021 DekaBank Deutsche Girozentrale13,000$155K0.0%N/A0.031% Breaking - The US Gov. Seized CITGO (Ad)Do you want an investment that can double or triple your money in the next three months? The US Court is currently auctioning off CITGO (the winning bid will be announced on July 22nd).Get all the details here.3/2/2021 Norges Bank50,000$588K0.0%N/A0.120% 2/16/2021 Clough Capital Partners L P399,399$4.69M0.3%-0.8%0.957% 2/12/2021 Caas Capital Management LP23,148$272K0.0%-60.4%0.055% 2/12/2021 Federated Hermes Inc.525,000$6.17M0.0%+2.9%1.258% 2/9/2021 Pivotal bioVenture Partners Investment Advisor LLC1,598,379$18.78M6.2%N/A3.831% 2/5/2021 BlackRock Inc.830,737$9.76M0.0%+80.6%1.991% 2/1/2021 Victory Capital Management Inc.179,524$2.11M0.0%+18.4%0.430% 12/30/2020 Deerfield Management Company L.P. Series C972,046$11.68M0.2%-22.7%2.330% 11/13/2020 Morgan Stanley26,693$321K0.0%-96.0%0.064% 11/12/2020 Federated Hermes Inc.510,000$6.13M0.0%+59.4%1.224% (Data available from 1/1/2016 forward) FUSN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of FUSN shares? During the previous two years, 48 institutional investors and hedge funds held shares of Fusion Pharmaceuticals. The most heavily invested institutionals were Federated Hermes Inc. ($104.62M), Avidity Partners Management LP ($62.47M), Blair William & Co. IL ($16.61M), Jane Street Group LLC ($13.52M), Perceptive Advisors LLC ($12.85M), FMR LLC ($10.86M), and Artal Group S.A. ($8.06M).Learn more on FUSN's institutional investors. What percentage of Fusion Pharmaceuticals stock is owned by institutional investors? 72.85% of Fusion Pharmaceuticals stock is owned by institutional investors. Learn more on FUSN's institutional investor holdings. Which institutional investors have been buying Fusion Pharmaceuticals stock? Of the 40 institutional investors that purchased Fusion Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Federated Hermes Inc. ($3.00M), Braidwell LP ($2M), Avidity Partners Management LP ($800.33K), Wellington Management Group LLP ($744.47K), Eagle Health Investments LP ($680.37K), RA Capital Management L.P. ($659.99K), and Jane Street Group LLC ($605.80K). How much institutional buying is happening at Fusion Pharmaceuticals? Institutional investors have bought a total of 10,866,224 shares in the last 24 months. This purchase volume represents approximately $83.45M in transactions. Which Fusion Pharmaceuticals major shareholders have been selling company stock? Of the 11 institutional investors that sold Fusion Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: FMR LLC ($503.61K), Artal Group S.A. ($250K), Blair William & Co. IL ($214.65K), Victory Capital Management Inc. ($131.01K), Eagle Health Investments LP ($100.60K), Tekla Capital Management LLC ($58.54K), and Pivotal bioVenture Partners Investment Advisor LLC ($37.40K). How much institutional selling is happening at Fusion Pharmaceuticals? Institutional investors have sold a total of 1,354,528 shares in the last 24 months. This volume of shares sold represents approximately $8.30M in transactions. Related Companies: Y-mAbs Therapeutics Major Shareholders MeiraGTx Major Shareholders Exelixis Major Shareholders Revolution Medicines Major Shareholders Halozyme Therapeutics Major Shareholders Krystal Biotech Major Shareholders CRISPR Therapeutics Major Shareholders ImmunityBio Major Shareholders Immunovant Major Shareholders SpringWorks Therapeutics Major Shareholders This page (NASDAQ:FUSN) was last updated on 6/8/2024 by MarketBeat.com Staff From Our PartnersCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...Brooks Enterprises | SponsoredShocking $16T Elon Musk Crypto LeakReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto mark...Crypto 101 Media | SponsoredUrgent alert: open this for a huge profit potentialThis groundbreaking technology that Tim calls “Inception” isn’t being talked about anywhere… not on Fox, Yahoo...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fusion Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fusion Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.